Human Gene Therapy, volume 36, issue 5-6, pages 618-627

Minimally Humanized Ezh2 Exon-18 Mouse Cell Lines Validate Preclinical CRISPR/Cas9 Approach to Treat Weaver Syndrome

William T Gibson 1, 2
, 
Tess C Lengyell 1
, 
Andrea J. Korecki 3
, 
Sanne M Janssen 2, 4
, 
Bethany A. Adair 2, 3
, 
Daniel Gamu 1
, 
Matthew C Lorincz 3, 4
, 
Elizabeth Simpson 2, 3
1
 
British Columbia Children’s Hospital Research Institute, Vancouver, Canada | 
2
 
3
 
Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, The University of British Columbia, Vancouver, Canada
4
 
Life Sciences Institute, Vancouver, Canada.
Publication type: Journal Article
Publication date: 2025-03-01
scimago Q2
SJR: 1.091
CiteScore: 6.5
Impact factor: 3.9
ISSN: 10430342, 15577422
Found 
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST | RIS | BibTex | MLA
Found error?